Skip to main content
. 2024 Oct 10;38(1):63–68. doi: 10.1080/08998280.2024.2406710

Table 3.

Adverse events reported according to balloon type

Adverse event Events Orbera Obalon ReShape Spatz
Abdominal distention 22 (1.31%) 17 (1.20%) 1 (1.10%) 0 (0%) 4 (3.36%)
Abdominal pain 368 (21.92%) 260 (18.36%) 30 (32.97%) 9 (16.98%) 69 (57.98%)
Aspiration 15 (0.89%) 10 (0.71%) 0 (0%) 3 (5.66%) 2 (1.68%)
Dehydration 47 (2.80%) 45 (3.18%) 0 (0%) 2 (3.77%) 0 (0%)
Dyspnea 2 (0.12%) 0 (0%) 2 (2.20%) 0 (0%) 0 (0%)
Failure of implant 408 (24.30%) 396 (27.97%) 0 (0%) 1 (1.89%) 11 (9.24%)
Gastritis 18 (1.07%) 16 (1.13%) 0 (0%) 2 (3.77%) 0 (0%)
Hiccups 1 (0.06%) 0 (0%) 1 (1.10%) 0 (0%) 0 (0%)
Gastroparesis 5 (0.30%) 5 (0.35%) 0 (0%) 0 (0%) 0 (0%)
Hypersensitivity/allergic reaction 2 (0.12%) 2 (0.14%) 0 (0%) 0 (0%) 0 (0%)
Malaise 22 (1.31%) 22 (1.55%) 0 (0%) 0 (0%) 0 (0%)
Nausea 201 (11.97%) 161 (11.37%) 22 (24.18%) 7 (13.21%) 11 (9.24%)
Obstruction/occlusion 90 (5.36%) 82 (5.79%) 3 (3.30%) 4 (7.55%) 1 (0.84%)
Pancreatitis 25 (1.49%) 23 (1.62%) 0 (0%) 0 (0%) 2 (1.68%)
Pulmonary embolism 8 (0.48%) 4 (0.28%) 0 (0%) 4 (7.55%) 0 (0%)
Pyrosis/heartburn 13 (0.77%) 13 (0.92%) 0 (0%) 0 (0%) 0 (0%)
Regurgitation 21 (1.25%) 21 (1.48%) 0 (0%) 0 (0%) 0 (0%)
Renal failure 7 (0.42%) 7 (0.49%) 0 (0%) 0 (0%) 0 (0%)
Ulcer formation 38 (2.26%) 15 (1.06%) 11(12.09%) 8 (15.09%) 4 (3.36%)
Unspecified infection 9 (0.54%) 9 (0.64%) 0 (0%) 0 (0%) 0 (0%)
Vomiting 357 (21.26%) 308 (21.75%) 21(23.08%) 13 (24.53%) 15 (12.61%)
Subtotal 1679 (95.40%) 1416 (84.34%) 91 (93.81%) 53 (84.13%) 119 (95.97%)
Serious adverse events  
 Cardiac arrest 10 (12.35%) 10 (16.67%) 0 (0%) 0 (0%) 0 (0%)
 Death 24 (29.63%) 21 (35.00%) 0 (0%) 2 (20%) 1 (20%)
 Hemorrhage/bleeding 12 (14.81%) 11 (18.33%) 0 (0%) 1 (10%) 0 (0%)
 Laceration(s) of esophagus 4 (4.94%) 2 (3.33%) 1 (16.67%) 1 (10%) 0 (0%)
 Perforation 23 (28.40%) 10 (16.67%) 5 (83.33%) 5 (50%) 3 (60%)
 Sepsis 8 (9.88%) 6 (10%) 0 (0%) 1 (10%) 1 (20%)
 Subtotal 81 (4.60%) 60 (16.67%) 6 (6.19%) 10 (15.87%) 5 (4.03%)
Total events 1760 (100%) 1476 (83.86%) 97 (5.51%) 63 (3.58%) 124 (7.05%)